The transcription factor facilitates EMT, tumor angiogenesis and chemoresistance by upregulating the expression of key intermediaries such as VEGF, vimentin, HIF-1α and P-glycoprotein [20, 33, 45]. This evidence concerns the gene HIF1A and neoplasm.